Nxstage Medical (Nasdaq: NXTM ) is expected to report Q4 earnings on Feb. 28. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Nxstage Medical's revenues will expand 11.4% and EPS will remain in the red.
The average estimate for revenue is $63.5 million. On the bottom line, the average EPS estimate is -$0.05.
Last quarter, Nxstage Medical reported revenue of $61.2 million. GAAP reported sales were 9.4% higher than the prior-year quarter's $55.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.04. GAAP EPS were -$0.04 for Q3 against -$0.10 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 38.8%, 380 basis points better than the prior-year quarter. Operating margin was -3.8%, 280 basis points better than the prior-year quarter. Net margin was -4.2%, 520 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $240.5 million. The average EPS estimate is -$0.27.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 140 members out of 173 rating the stock outperform, and 33 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 40 give Nxstage Medical a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Nxstage Medical is outperform, with an average price target of $19.54.
Is Nxstage Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Nxstage Medical to My Watchlist.